New long-term data from the CSP 474 trial offers a challenge to some of the conventional wisdom around graft choice in CABG surgery and may further the debate over recent guideline recommendations.
Presenting long-term mortality numbers from the VA study at the European Association for Cardio-Thoracic Surgery (EACTS) 2022 conference last week, researchers showed that when an adjunctive graft was needed in patients with multivessel coronary artery disease, use of the radial artery instead of a saphenous vein did not confer a survival advantage.
Even with the new results, though, surgeons should, when possible, be aiming to perform multiarterial grafts in patients with multivessel coronary disease, say researchers, although surgical skills should drive decisions as to the optimal conduit.
Yes, multiarterial grafting should be encouraged, but it should be used in select patients, in select coronary targets, and by experienced surgeons, lead researcher Faisal Bakaeen, MD (Cleveland Clinic, OH), told TCTMD. At your center, if youre comfortable using radial grafts or any arterial grafts, such as the right internal thoracic artery, please continue to use them because surgeon experience is an important determinant of outcomes.
But if surgeons instead go with a saphenous vein graft, for whatever reason, these late CSP 474 data suggest that survival is not compromised.
Guideline Implications
The most recent European guidelines on myocardial revascularization recommend a strategy that incorporates multiple arterial grafts in appropriately selected patients, with the additional arterial graft, typically the radial artery, preferred over the saphenous vein following an initial left internal thoracic artery (LITA) to the LAD (class I, level of evidence B). Bilateral internal thoracic artery grafting is also recommended if patients dont have a high risk for sternal wound infection (class IIa, level of evidence B).
Graft choice was more contentious in the United States guidelines, where the Society of Thoracic Surgeons and American Association for Thoracic Surgery (AATS) recently declined to endorse the 2021 guidelines for coronary artery revascularization put forward by the American College of Cardiology (ACC), American Heart Association (AHA), and the Society for Cardiovascular Angiography and Interventions (SCAI), in part due to the class 1 recommendation that the radial artery should be preferentially used as the adjunctive CABG conduit in multivessel CAD. The STS position is that when a second arterial graft is needed beyond the LITA-to-LAD graft, it should be either the right internal thoracic artery or radial artery, although the strength of that recommendation is tempered (class IIa, level of evidence B).
As Bakaeen explained to TCTMD, when you give something a class I recommendation, it becomes the standard of care, but its not a generalizable standard of care.
No Mortality Difference at 17 Years
CSP 474 originally included 757 patients (mean age 61 years, 99% male, 90% white) undergoing elective CABG surgery between 2003 and 2009 at 11 Veterans Affairs (VA) medical centers in the United States. For all surgeries, the LITA was used to graft the LAD when possible and the other vessels grafted with either the radial artery or saphenous vein. Nearly 60% of secondary grafts involved either the radial artery or saphenous vein to the circumflex artery, while a little less than one-third were to the right coronary artery.
The primary endpoint of the original studyangiographic graft patency at 1 yearshowed there was no difference between the two procedures. For this follow-up analysis, researchers evaluated long-term mortality in 733 patients showing that, over more than 17 years, there was no significant difference in the risk of all-cause mortality between those who received a radial artery graft and those who received a saphenous vein graft (HR 0.99; 95% 0.8-1.2).
In an analysis of graft patency at 5 years, assessed with angiography in a subset of 196 patients whose grafts were patent at 1 year, occlusions were seen in three patients treated with a radial artery and two with a saphenous vein graft.
Bakaeen said the VA database only allowed them a look at all-cause mortality, which is a both a strength and weakness of the current study.
We cant rule out a potential benefit of the radial artery in the long run when it comes to major adverse cardiovascular events, because we didnt have reliable data, he said. Neither did we have reliable data on patency. The incomplete patency results that we do have seem to indicate an absence of signal with respect to the superiority of the radial graft, but we cant say with certainty that we can rule out a radial benefit.
Real-world Patients in VA Study
In a patient-level meta-analysis published in 2018, known as the Radial Artery Database International Alliance (RADIAL), investigators showed that use of the radial artery over the saphenous vein was associated with a 33% lower risk of adverse cardiac events. In follow-up angiography, which was performed after a mean of 50 months, the radial artery was associated with significantly lower rates of occlusion compared with the saphenous vein.
Mario Gaudino, MD (NewYork-Presbyterian/Weill Cornell Medicine, NY), who led that analysis, told TCTMD that CSP 474 is the only trial that has not shown any difference in graft patency at 1 year, so the absence of a mortality benefit in long-term follow-up isnt surprising.
He pointed out that using the radial artery is associated with a lower risk of MI and repeat revascularization (28% and 50% reductions in the RADIAL meta-analysis, respectively), but wasnt associated with any difference in survival. Any potential mortality effect would be quite small or negligible, said Gaudino in an email, as the status of a non-LAD target is unlikely to affect survival. MI and repeat revascularization are important outcomes, he said, and mortality alone does not tell the whole story.
These CSP 474 data notwithstanding, Gaudino stressed the overall risk-benefit of radial artery grafting is very favorable, noting that the incidence of harvesting-site complications is very low as opposed to using the right internal thoracic artery.
Cardiac surgeon Stephen Fremes, MD (University of Toronto/Sunnybrook Health Sciences Centre, Canada), said the radial artery should be routinely preferred over the saphenous vein when used to treat a moderate-sized, left-sided target vessel with a high-grade lesion or right-sided vessel with subocclusive disease.
Patients also must be good candidates for the radial grafting, such as by having adequate ulnar collateral circulation and a radial artery at least 2-3 mm in diameter on noninvasive imaging. Obesity, diabetes, and sex dont impact the decision to use the radial artery, but advanced chronic kidney disease and peripheral vascular disease are both contraindications. Its also relatively contraindicated in patients with poor LV function, he said.
Anatomically, the [radial artery] is usually constructed as an aortocoronary graft, said Fremes in an email. In that configuration, it can typically reach to all coronary targets but may not reach to targets in the posterolateral territory,on the opposite site of the heart from the ascending aorta. When used as a composite graft, it can reach all territories.
In 2004, Fremes, along with first author Nimesh Desai, MD (Sunnybrook Health Sciences Centre), published a study showing that use of the radial artery was associated with a lower rate of graft occlusion compared with saphenous vein grafts. Fremes also noted that he was involved in developing the ACC/AHA/SCAI guidelines for coronary revascularization. While the surgical societies chose not to endorse the guidelines, Fremes, who remained a listed co-author on them, believes they ultimately got it right with respect to the radial artery class I recommendation.
VA Study Achieved Excellent Outcomes
To TCTMD, Bakaeen said studies supporting the radial artery over the saphenous vein for secondary grafts are largely observational, and that randomized controlled trials conducted to date have been small and performed at centers where operators are experienced in performing radial artery grafting. Those results, said Bakaeen, are not really generalizable to all operators, leaving some uncertainty about the relative merits of radial grafting. In addition to those concerns, most studies lacked robust follow-up and event adjudication, with only the RAPCO study designed to assess outcomes long-term.
The CSP 474 study is the largest study to date and includes surgeons working at VA centers, making it more generalizable with respect to US practice patterns, he said. He pointed out that the 1-year patency rate with either the radial artery or saphenous vein grafts was 89%, which is comparable to outcomes achieved by the very best hospitals.
Nobody can argue that these were suboptimal procedures or a lower-standard surgery, said Bakaeen. In fact, I think they received excellent operations.
For Bakaeen, an ideal patient for a radial graft is one who is younger, or who has a life expectancy beyond 10 years, has a severely diseased and critical non-LAD target, and anatomy favoring harvesting of the radial artery. When using the radial artery to bypass a severe blockage, this is less likely to result in competitive flow, the phenomenon where there is an equilibrium between the residual flow through the native coronary artery and flow through the bypass graft at the anastomosis. Competitive flow, he said, is an important predictor of radial graft patency.
Originally posted here:
Adjunctive Radial Artery Grafts No Better Than SVGs in Multivessel CABG - TCTMD
- Home - MedStar Heart & Vascular Institute - April 16th, 2018 [April 16th, 2018]
- Guidelines for Standards in Cardiac Surgery - April 16th, 2018 [April 16th, 2018]
- Cardiac Surgery - University of Ottawa Heart Institute - June 16th, 2018 [June 16th, 2018]
- Cardiac Surgery | UNC Medical Center, Hospitals Chapel ... - June 18th, 2018 [June 18th, 2018]
- Heart Surgery | Seattle Childrens Hospital - June 18th, 2018 [June 18th, 2018]
- Pediatric Cardiac Surgery | CHKD | Norfolk, VA - June 18th, 2018 [June 18th, 2018]
- Cardiac Surgery | McLaren Port Huron - July 4th, 2018 [July 4th, 2018]
- CardioVascular Thoracic Institute (CVTI) | The most ... - July 23rd, 2018 [July 23rd, 2018]
- Top Cardiac Surgery COST in India| Benefit - IndianHealthGuru - July 27th, 2018 [July 27th, 2018]
- Cardiac Surgery - Atrial Septal Defect - August 6th, 2018 [August 6th, 2018]
- Cardiac Surgery | Stony Brook Medicine - August 6th, 2018 [August 6th, 2018]
- Cardiac Surgery in the Adult Fifth Edition: Lawrence H. Cohn ... - August 6th, 2018 [August 6th, 2018]
- Pioneers of Cardiac Surgery: 9780826515940: Medicine & Health ... - August 6th, 2018 [August 6th, 2018]
- Cardiovascular Surgery Department | Cleveland Clinic - August 6th, 2018 [August 6th, 2018]
- Cardiac Surgery - Massachusetts General Hospital, Boston, MA - September 19th, 2018 [September 19th, 2018]
- Cardiac Surgery | Surgery | UC Cincinnati College of ... - September 25th, 2018 [September 25th, 2018]
- Cardiothoracic surgery - Wikipedia - September 25th, 2018 [September 25th, 2018]
- Cardiac Surgery | NorthShore - September 25th, 2018 [September 25th, 2018]
- Open Heart Surgery - Cardiac Surgery - University of ... - September 25th, 2018 [September 25th, 2018]
- Heart Surgery | Cleveland Clinic - September 25th, 2018 [September 25th, 2018]
- Cardiac Surgery - Ventricular Assist Devices (VAD) - October 4th, 2018 [October 4th, 2018]
- VCSQI | Virginia Cardiac Services Quality Initiative ... - October 12th, 2018 [October 12th, 2018]
- Cardiac Surgery | Boston Medical Center - October 15th, 2018 [October 15th, 2018]
- Cardiac Surgery | WVU Heart and Vascular Institute - November 10th, 2018 [November 10th, 2018]
- Cardiac Surgery - Heart Valve, Bypass | GW Hospital - November 13th, 2018 [November 13th, 2018]
- Cardiac Surgery - Department of Surgery - University of ... - November 29th, 2018 [November 29th, 2018]
- Cardiac Surgery - Jersey Shore University Medical Center - December 7th, 2018 [December 7th, 2018]
- Blunt Cardiac Injury - The American Association for the ... - December 20th, 2018 [December 20th, 2018]
- Minimally invasive cardiac surgery - Wikipedia - December 20th, 2018 [December 20th, 2018]
- Heart Surgery | Private cardiac specialists in London ... - December 20th, 2018 [December 20th, 2018]
- Cardiac Surgery - Waterbury Hospital - December 20th, 2018 [December 20th, 2018]
- Cardiac surgery - Wikipedia - December 25th, 2018 [December 25th, 2018]
- Heart Surgery | Memorial Healthcare System - December 31st, 2018 [December 31st, 2018]
- A Step-By-Step Look at Open Heart Bypass Surgery - December 31st, 2018 [December 31st, 2018]
- Cardiac Surgery - Erlanger - December 31st, 2018 [December 31st, 2018]
- Inova Cardiac and Thoracic Surgery | Northern VA & DC - Inova - March 6th, 2019 [March 6th, 2019]
- Cardiac Surgery | Heart and Vascular Center | Dartmouth ... - March 13th, 2019 [March 13th, 2019]
- Cardiovascular Medicine and Cardiac Surgery - April 1st, 2019 [April 1st, 2019]
- Minimally invasive heart surgery - Mayo Clinic - April 3rd, 2019 [April 3rd, 2019]
- Home > Cardiac Surgery | Surgery | Yale School of Medicine - April 16th, 2019 [April 16th, 2019]
- Heart and Vascular Care Services - UR Medicine, University ... - April 18th, 2019 [April 18th, 2019]
- Welcome! | LHSC - April 20th, 2019 [April 20th, 2019]
- Cardiac Surgery | Department of Surgery | The University ... - April 20th, 2019 [April 20th, 2019]
- Coronary bypass surgery - Mayo Clinic - April 23rd, 2019 [April 23rd, 2019]
- Cardiovascular Surgery - Overview - Mayo Clinic - April 23rd, 2019 [April 23rd, 2019]
- Cardiac Surgery | McLaren Health Care - April 23rd, 2019 [April 23rd, 2019]
- Volunteer opens heart to his faith after healing cardiac ... - April 23rd, 2019 [April 23rd, 2019]
- Heart Surgery - UChicago Medicine - April 27th, 2019 [April 27th, 2019]
- Heart Surgery | UM St. Joseph Medical Center - May 13th, 2019 [May 13th, 2019]
- Cardiac Surgery - Billings Clinic - May 13th, 2019 [May 13th, 2019]
- Cardiology and Cardiac Surgery - Chicago Cardiologists and ... - May 23rd, 2019 [May 23rd, 2019]
- Cardiac Surgery | Michigan Medicine | University of Michigan - September 11th, 2019 [September 11th, 2019]
- Guidelines for Perioperative Care in Cardiac Surgery ... - September 11th, 2019 [September 11th, 2019]
- Cannula Market To Flourish And Reach USD 433 Million By 2025 - ZMR News Network - October 4th, 2019 [October 4th, 2019]
- Heart Health: Dr Panda says one should never give up on a patient - Republic World - October 4th, 2019 [October 4th, 2019]
- Minimally Invasive Surgery Market 2024 By Manufacturers, Investment Feasibility, Cost Structure And Swot Analysis - The Washington Observer - October 4th, 2019 [October 4th, 2019]
- Michael Schumacher health latest: What is stem cell therapy and how will it help Schumi? - Express.co.uk - October 4th, 2019 [October 4th, 2019]
- Cooperative insurance: Novel financing model aims to deliver healthcare to the middle-class segment - The Hindu BusinessLine - October 4th, 2019 [October 4th, 2019]
- Optimism Linked to Lower Risk of Cardiovascular Events and Death - Cath Lab Digest - October 4th, 2019 [October 4th, 2019]
- Global Cardiac Surgery Devices Market 2019 Innovative Trends and Insights Research upto 2024 - Markets Gazette - October 4th, 2019 [October 4th, 2019]
- Abiomed Receives FDA PMA Approval for Impella 5.5 With SmartAssist - Diagnostic and Interventional Cardiology - October 4th, 2019 [October 4th, 2019]
- Economics of Cochlear Implant Utilization : The Hearing Journal - LWW Journals - October 4th, 2019 [October 4th, 2019]
- How to Keep the Weight Off After Bariatric Surgery - Health Essentials from Cleveland Clinic - October 4th, 2019 [October 4th, 2019]
- Heart Lung Machine Market to Upsurge at 6.13% CAGR by 2023, Owing to Increasing Demand From the Healthcare Sector: Radiant Insights, Inc. - PRNewswire - October 4th, 2019 [October 4th, 2019]
- Annadale toddler born with rare condition is fighting for her life - SILive.com - October 4th, 2019 [October 4th, 2019]
- Ocala Health earns distinction, ranks among top within HCA open heart programs - Ocala News - October 4th, 2019 [October 4th, 2019]
- External Validation Of The Surgical Mortality Probability Model (S-MPM | TCRM - Dove Medical Press - October 4th, 2019 [October 4th, 2019]
- CytoSorb Removal of Ticagrelor Intraoperatively Results in Projected Cost Savings of Approximately $5,000 in Each Patient Undergoing Emergency Cardiac... - October 4th, 2019 [October 4th, 2019]
- Transcatheter Tricuspid Fix Bests Meds Alone in Early Results - Medscape - October 15th, 2019 [October 15th, 2019]
- Senior Lecturer/Associate Professor in Medical Statistics job with UNIVERSITY OF BRISTOL | 183393 - Times Higher Education (THE) - October 15th, 2019 [October 15th, 2019]
- Complicated surgery at NICVD saves life of nine-year-old boy - The News International - October 15th, 2019 [October 15th, 2019]
- Angion Announces Several Strategic Additions to its Management Team to Support the Future Development and Commercialization of ANG-3777 - Yahoo... - October 15th, 2019 [October 15th, 2019]
- 'Sky is the limit' for heart treatment without invasive surgery - Ottawa Citizen - October 15th, 2019 [October 15th, 2019]
- Executive Profile: Dr. David Anschel - Long Island Business News - October 15th, 2019 [October 15th, 2019]
- Heart surgeon and author reveals how he once set fire to patient - The Guardian - October 15th, 2019 [October 15th, 2019]
- Demolition paves way for heart, vascular center - Midland Daily News - October 15th, 2019 [October 15th, 2019]
- The basics of research | TNS - The News on Sunday - October 15th, 2019 [October 15th, 2019]
- Senior Lecturer/Associate Professor in Medical Statistics job with UNIVERSITY OF BRISTOL | 183345 - Times Higher Education (THE) - October 15th, 2019 [October 15th, 2019]
- Sparks, Accusations Fly Over Conduct of EXCEL Trial - Medscape - October 15th, 2019 [October 15th, 2019]
- More Heart Valve Patients May Choose Minimally Invasive Procedure - Newswise - October 15th, 2019 [October 15th, 2019]